左主干冠状动脉支架置入术后双联抗血小板治疗的最佳持续时间 - Suppr

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.

作者信息

Brener Sorin J, Serruys Patrick W, Morice Marie-Claude, Mehran Roxana, Kappetein Arie Pieter, Sabik Joseph F, Liu Yangbo, Dressler Ovidiu, Ben-Yehuda Ori, Stone Gregg W

出版信息

J Am Coll Cardiol. 2018 Oct 23;72(17):2086-2087. doi: 10.1016/j.jacc.2018.07.084.

DOI:10.1016/j.jacc.2018.07.084

PMID:30336833

Abstract

摘要

相似文献

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.左主干冠状动脉支架置入术后双联抗血小板治疗的最佳持续时间

J Am Coll Cardiol. 2018 Oct 23;72(17):2086-2087. doi: 10.1016/j.jacc.2018.07.084.

Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?药物洗脱支架置入术后仅进行30天双重抗血小板治疗：“短期”治疗是否具有优势？

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e21-e25. doi: 10.2459/JCM.0000000000000559.

Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.急性冠状动脉综合征冠状动脉支架置入术后优化双联抗血小板治疗的策略

J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):347-355. doi: 10.1177/1074248416683048. Epub 2016 Dec 21.

Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.药物洗脱支架置入术后短期（≤6个月）与长期（≥12个月）双重抗血小板治疗：一项随机临床试验的荟萃分析

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):34-40. doi: 10.1002/ccd.25520. Epub 2014 May 6.

Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).药物洗脱支架经皮冠状动脉介入治疗后高血小板反应性临床影响的性别差异：ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）结果

Circ Cardiovasc Interv. 2017 Feb;10(2). doi: 10.1161/CIRCINTERVENTIONS.116.003577.

Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.根据治疗中的血小板反应性评估，急性冠状动脉综合征后转换双联抗血小板治疗的获益：TOPIC-VASP 预先指定分析，TOPIC 随机研究。

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2560-2570. doi: 10.1016/j.jcin.2017.08.044.

Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis.短期双联抗血小板治疗后停用氯吡格雷患者发生早期不良事件的风险：一项个体参与者数据分析。

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1621-1630. doi: 10.1016/j.jcin.2017.06.001.

Should all stent patients have prolonged dual antiplatelet therapy?所有支架植入患者都应该接受延长的双联抗血小板治疗吗？

JACC Cardiovasc Interv. 2015 May;8(6):873-875. doi: 10.1016/j.jcin.2015.04.001.

Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials.药物洗脱支架置入 1 年后继续双联抗血小板治疗：随机试验的荟萃分析。

Circ Cardiovasc Interv. 2017 May;10(5). doi: 10.1161/CIRCINTERVENTIONS.116.004139.

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.急性冠状动脉综合征或经皮冠状动脉介入治疗后双联抗血小板治疗疗程的个体化

Circulation. 2016 May 24;133(21):2094-8. doi: 10.1161/CIRCULATIONAHA.115.021158.

引用本文的文献

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention.复杂经皮冠状动脉介入治疗中双重抗血小板治疗的类型和持续时间

US Cardiol. 2020 Nov 23;14:e14. doi: 10.15420/usc.2020.13. eCollection 2020.

Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Stenosis: 6 versus 12 Months.非保护左主干冠状动脉狭窄经皮冠状动脉介入治疗后双联抗血小板治疗的持续时间：6个月与12个月对比

J Clin Med. 2024 Sep 13;13(18):5449. doi: 10.3390/jcm13185449.

State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan.日本左主干冠状动脉疾病的最新经皮冠状动脉介入治疗

Cardiovasc Interv Ther. 2024 Oct;39(4):386-402. doi: 10.1007/s12928-024-01030-4. Epub 2024 Jul 30.

Left Main Coronary Artery Disease: A Contemporary Review of Diagnosis and Management.左主干冠状动脉疾病：诊断与管理的当代综述

Rev Cardiovasc Med. 2024 Feb 18;25(2):66. doi: 10.31083/j.rcm2502066. eCollection 2024 Feb.

Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.左主干冠状动脉疾病患者中使用 4 个月双联抗血小板治疗的可生物吸收聚合物药物洗脱支架与使用 12 个月双联抗血小板治疗的耐用聚合物药物洗脱支架的比较：IDEAL-LM 随机试验。

EuroIntervention. 2022 Apr 22;17(18):1467-1476. doi: 10.4244/EIJ-D-21-00514.

Fluttering Bioprosthetic Valve Leaflet Detected by Intravascular Ultrasound During Valve-in-Valve Transcatheter Aortic Valve Replacement.在瓣中瓣经导管主动脉瓣置换术中通过血管内超声检测到生物瓣叶飘动

JACC Case Rep. 2021 Jun 16;3(6):910-912. doi: 10.1016/j.jaccas.2021.04.032. eCollection 2021 Jun.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献